Thursday, April 30, 2020 9:35:25 AM
to support the Company’s application to the U.S. Food and Drug Administration (FDA) before the end of April 2020
to support the Company’s application to the U.S. Food and Drug Administration (FDA) before the end of April 2020
If they had submitted the Application to the FDA
they should have reported that
So either (a) they did not submit and the stock is down
or (b) they are stupid and did not publish that they followed through as promised and the stock is down
.
either way the stock is down as J & J and everybody else is now making home testing kits
AND ACTUALLY DOING PR AND GETTING THINGS DONE
to support the Company’s application to the U.S. Food and Drug Administration (FDA) before the end of April 2020
If they had submitted the Application to the FDA
they should have reported that
So either (a) they did not submit and the stock is down
or (b) they are stupid and did not publish that they followed through as promised and the stock is down
.
either way the stock is down as J & J and everybody else is now making home testing kits
AND ACTUALLY DOING PR AND GETTING THINGS DONE
Recent BNBX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:09:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:08:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:07:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:06:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:06:14 PM
- Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 03/25/2026 12:09:48 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/24/2026 08:15:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 08:06:00 PM
- BNB Plus Corp. Announces European Patent Grant for Fundamental Technology Underlying its Linea™ IVT Platform • Business Wire • 03/18/2026 12:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/12/2026 09:24:23 PM
- BNB Plus Corp. (BNBX) Receives Two New Orders for LineaDNA™ from Genetic Medicine Developers • Business Wire • 02/24/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2026 09:16:58 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/13/2026 07:49:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2026 09:32:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 09:11:07 PM
- BNB Plus Corp. (BNBX) Appoints James Haft as Independent Board Director • Business Wire • 02/05/2026 01:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/30/2026 09:06:16 PM
- Digital Asset Virtual Investor Conference: Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 01/28/2026 01:35:00 PM
- BNB Plus Corp. (BNBX) to Present at the Digital Asset Virtual Investor Conference January 27th • Business Wire • 01/27/2026 01:00:00 PM
- BNB Plus Corp. (BNBX) to Present at the Digital Asset Virtual Investor Conference January 27th • GlobeNewswire Inc. • 01/27/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2026 09:10:46 PM
- BNB Plus Corp. (BNBX) Receives $1.2M Accelerated LineaDNA™ Order • Business Wire • 01/05/2026 01:01:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/30/2025 01:27:25 PM
